clinical trial · NCT07696091
Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet
Reistone Biopharma Company Limited·phase1·not yet recruiting·n = 40
Non-cystic Fibrosis Bronchiectasis、Chronic Sinusitis Without Nasal Polyps、Chronic Obstructive Pulmonary DiseaseRSS0343 Tablet; Rifampicin CapsulesRSS0343 Tablet; Clarithromycin Tablets
brief summary
This study is a single-center, single-sequence, self-controlled, open design, aiming to investigate the effects of rifampicin and clarithromycin on the pharmacokinetics of RSS0343 in humans.
started
Jul 1, 2026
primary completion
Sep 1, 2026
completion
Sep 1, 2026
last updated
Jul 10, 2026
official title
A Single-center, Single-sequence, Self-controlled Open Design Study , to Investigate the Effects of Rifampicin and Clarithromycin on the Pharmacokinetics of RSS0343.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol